Skip to main content
. 2020 Aug 17;12(3):346–356. doi: 10.1111/jdi.13355

Table 1.

Chronic kidney disease as a result of type 2 diabetes mellitus numbers and age‐standardized rates globally and by Sociodemographic Index quintile

Region metric All ages (95% UI) Age‐standardized rate/100,000 (95% UI)
2017 n Male + female 2017 n Male 2017 n Female 1990–2017 change 2017 Male + female 2017 Male 2017 Female 1990–2017 change
Global
Incidence 2,352,496 (2,063,870–2,680,907) 1,096,618 (956,874–1,260,600) 1,255,878 (1,102,679–1,428,199) 0.74 (0.37–0.92) 29.15 (25.62–33.24) 28.68 (25.05–32.76) 29.62 (26.05–33.68) −0.09 (–0.22 to 0)
Deaths 348,959 (306,839–395,903) 177,783 (152,861–203,857) 171,176 (151,399–192,499) 1.45 (1.3–1.57) 4.50 (3.95–5.10) 5.12 (4.42–5.87) 3.98 (3.52–4.48) 0.19 (0.12–0.24)
DALYs 8,122,240 (7,117,016–9,245,108) 4,277,520 (3,696,214–4,896,674) 3,844,720 (3,377,393–4,343,161) 1.13 (1.02–1.22) 100.85 (88.43–114.79) 112.71 (97.73–128.79) 90.21 (79.18–101.98) 0.09 (0.04–0.14)
Low SDI
Incidence 260,507 (227,908–297,705) 124,342 (108,199–144,036) 136,165 (119,523–155,229) 0.81 (0.21–1.14) 34.71 (30.42–39.75) 33.63 (29.34–38.81) 35.77 (31.48–40.56) −0.07 (−0.24 to 0.04)
Deaths 29,265 (24,797–35,733) 16,398 (13,556–21,970) 12,867 (10,822–15,174) 0.92 (0.75–1.11) 4.89 (4.16–6.02) 5.41 (4.46–7.28) 4.37 (3.66–5.11) −0.1 (−0.17 to −0.02)
DALYs 786,251 (670,435–930,703) 433,698 (365,303–557,594) 352,553 (302,284–406,577) 0.81 (0.67–0.98) 111.39 (95.40–132.03) 123.14 (103.11–157.52) 99.78 (85.80–115.21) −0.13 (−0.19 to –0.05)
Low‐middle SDI
Incidence 423,104 (371,682–486,695) 200,437 (175,435–232,547) 222,666 (195,918–255,105) 0.83 (0.28–1.11) 34.01 (29.81–38.78) 33.39 (29.18 −38.23) 34.63 (30.43–39.40) −0.05 (−0.22 to 0.04)
Deaths 70,030 (60,290–81,419) 38,150 (31,024–44,730) 31,879 (37,046–27,281) 1.25 (1.06–1.43) 6.61(5.69–6.67) 7.55 (6.21–8.86) 5.76 (4.92–6.67) 0.06 (−0.02 to 0.15)
DALYs 1,800,887 (1,542,337–2,067,625) 980,298 (813,454–1,135,050) 820,589 (706,592–945,278) 1.08 (0.93–1.23) 150.13 (129.31–171.79) 168.93 (140.10–196.06) 132.61 (114.43–156.56) 0.02 (−0.06 to 0.09)
Middle SDI
Incidence 583,963 (512,850–667,380) 278,046 (243,459–317,437) 305,917 (267,582–350,036) 1.03 (0.46–1.3) 25.87 (22.68–29.58) 25.57 (22.35–29.23) 26.15 (22.92–29.83) –0.06 (−0.23 to 0.03)
Deaths 124,801 (107,996–141,733) 65,126 (54,432–74,652) 59,675 (52,475–67,285) 1.93 (1.7–2.1) 6.14 (5.31–6.96) 6.92 (5.72–7.91) 5.47 (4.82–6.16) 0.16 (0.07–0.22)
DALYs 2,933,391 (2,551,167–3,329,395) 1,568,835 (1,321,386–1,786,662) 1,364,556 (1,194,741–1,545,625) 1.53 (1.38–1.67) 131.66 (114.67–149.32) 149.92 (123.50–167.92) 117.66 (103.20–133.13) 0.11 (0.04–0.16)
High‐middle SDI
Incidence 465,632 (405,314–534,640) 204,678 (177,599–235,904) 260,954 (228,354–297,081) 0.61 (0.38–0.75) 25.63 (22.46–29.28) 24.18 (21.12–27.74) 26.95 (23.65–30.61) −0.14 (−0.23 to −0.07)
Deaths 47,620 (41,585–54,568) 23,265 (19,918–27,284) 24,355 (21,240–27,660) 1.16 (0.99–1.28) 2.81 (2.45–3.21) 3.22 (2.78–3.76) 2.52 (2.20–2.86) 0.06 (−0.02 to 0.12)
DALYs 1,146,288 (995,292–1,315,358) 572,617 (490,814–661,176) 573,671 (499,115–654,542) 0.82 (0.72–0.91) 63.75 (55.44–72.88) 69.75 (60.33–80.44) 58.86 (51.11–67.08) −0.04 (−0.09 to 0)
High SDI
Incidence 613,315 (533,337–706,082) 286,258 (246,723–331,251) 327,057 (286,210–375,040) 0.54 (0.42–0.66) 28.34 (24.59–32.47) 28.86 (25.02–33.20) 27.90 (24.36–31.85) −0.07 (−0.14 to 0)
Deaths 76,017 (654,40–86,671) 34,223 (29,383–39,648) 41,794 (35,939–47,453) 1.48 (1.31–1.65) 2.97 (2.59–3.37) 3.35 (2.89–3.87) 2.68 (2.34–3.03) 0.28 (0.22–0.33)
DALYS 1,426,713 (1,253,433–1,613,573) 707,054 (616,874–805,570) 719,659 (633,554–806,863) 0.98 (0.9–1.07) 64.77 (56.96–73.38) 71.88 (63.01–81.67) 58.65 (51.42–66.43) 0.17 (0.12–0.21)

DALYs, disability‐adjusted life years; SDI, Sociodemographic Index.